Simos Symeonidis
investorMale0.0Global Dominance: 0.00%
Simos Symeonidis is a co-founder of Kos Biotechnology Partners, an international investment fund focused on biotechnology and pharmaceutical technologies. The fund aims to manage €120 million initially, with plans to increase it to €150 million, targeting advancements in drug-related technologies.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Simos Symeonidis is a former molecular biologist and academic who co-founded Delsona Therapeutics with Dr. Konofagou.
Ξεπερνώντας το «τείχος» του εγκεφάλουKathimerini·
Greece· 2025-09-18
Greece· 2025-09-18
Simos Symeonidis highlighted the serious risks posed by changes in funding and staffing at NIH and FDA.
Χαρτογραφώντας την ιατρική επανάσταση | Η ΚΑΘΗΜΕΡΙΝΗKathimerini·Greece· 2025-05-24
Greece· 2025-05-24
Simos Symeonidis is a doctor and co-founder of Kos Biotechnology Partners, an investment fund focusing on biotechnology.
Χρηματοδότηση 31,4 εκατ. ευρώ από τη Nvidia σε startup με ελληνικό dnaKathimerini·Greece· 2025-03-02
Greece· 2025-03-02
